Pharmaceutical Pricing and Reimbursement and the Broader Pharmaceutical Policy Environment
Source: SourceOECD Social Issues/Migration/Health, Volume 2008, Number 6, September 2008 , pp. 112-169(58)
Abstract:The pricing and reimbursement policies used in OECD countries are described and analysed in this chapter. It begins with a description of the coverage schemes that serve to pool risks and defray the pharmaceutical costs borne by individuals. It continues by describing the pharmaceutical pricing schemes employed in OECD countries, including the methods used to limit pharmaceutical prices and define reimbursement price levels. A concluding section provides an overview of aspects of intellectual property rights and marketing authorisation policies that are most important in defining the pharmaceutical policy environment.
Document Type: Review Article
Publication date: September 1, 2008